1. Home
  2. PTCT vs GFF Comparison

PTCT vs GFF Comparison

Compare PTCT & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • GFF
  • Stock Information
  • Founded
  • PTCT 1998
  • GFF 1959
  • Country
  • PTCT United States
  • GFF United States
  • Employees
  • PTCT N/A
  • GFF N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • GFF Building Products
  • Sector
  • PTCT Health Care
  • GFF Industrials
  • Exchange
  • PTCT Nasdaq
  • GFF Nasdaq
  • Market Cap
  • PTCT 3.7B
  • GFF 3.3B
  • IPO Year
  • PTCT 2013
  • GFF N/A
  • Fundamental
  • Price
  • PTCT $48.52
  • GFF $68.73
  • Analyst Decision
  • PTCT Buy
  • GFF Strong Buy
  • Analyst Count
  • PTCT 13
  • GFF 4
  • Target Price
  • PTCT $62.31
  • GFF $99.00
  • AVG Volume (30 Days)
  • PTCT 1.6M
  • GFF 381.1K
  • Earning Date
  • PTCT 05-06-2025
  • GFF 05-08-2025
  • Dividend Yield
  • PTCT N/A
  • GFF 1.05%
  • EPS Growth
  • PTCT N/A
  • GFF 30.60
  • EPS
  • PTCT 7.51
  • GFF 4.82
  • Revenue
  • PTCT $1,772,758,000.00
  • GFF $2,551,604,000.00
  • Revenue This Year
  • PTCT $99.06
  • GFF N/A
  • Revenue Next Year
  • PTCT N/A
  • GFF $3.23
  • P/E Ratio
  • PTCT $6.46
  • GFF $14.26
  • Revenue Growth
  • PTCT 91.12
  • GFF N/A
  • 52 Week Low
  • PTCT $28.72
  • GFF $55.01
  • 52 Week High
  • PTCT $58.38
  • GFF $86.73
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 55.25
  • GFF 46.87
  • Support Level
  • PTCT $44.54
  • GFF $67.50
  • Resistance Level
  • PTCT $49.15
  • GFF $69.42
  • Average True Range (ATR)
  • PTCT 1.72
  • GFF 1.60
  • MACD
  • PTCT 0.48
  • GFF -0.31
  • Stochastic Oscillator
  • PTCT 87.67
  • GFF 27.39

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About GFF Griffon Corporation

Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.

Share on Social Networks: